Analyst firms · Jefferies · CHE

Jefferies CHE price target and rating history

Chemed Corp (CHE) · Health Care

Jefferies rates Chemed Corp (CHE) Buy with a $620 price target, as of its latest action on Oct 28, 2026. It has published 4 rating actions on CHE since July 2025, including 2 upgrades and 1 downgrade. Across 3 firms with a CHE price target in the last 12 months, the median target is $620. Jefferies's target matches it.

Current rating
Buy
Price target
$620
Median target, all firms
$620
Actions on CHE
4

Jefferies price target on CHE

$620$548$4752026
Jefferies price target on CHE, each point a stated target, July 2025 to October 2026.

Every Jefferies rating on CHE

How other firms rate CHE

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesBuy$620Oct 28, 2026
UBSBuy$650Sep 25, 2026
RBC Capital MarketsSector Perform$422Feb 27, 2026

Questions about Jefferies and CHE

What is Jefferies's price target for CHE?
Jefferies's latest stated price target for Chemed Corp (CHE) is $620, from its action on Oct 28, 2026.
What is Jefferies's rating on CHE?
Jefferies rates CHE Buy, a bullish rating, as of Oct 28, 2026.
When did Jefferies last change its view on CHE?
On Oct 28, 2026, Jefferies upgrades to Buy from Hold, price target $620.
How does Jefferies's CHE target compare with other analysts?
Across 3 firms with a CHE price target in the last 12 months, the median target is $620. Jefferies's target matches it.

More CHE rating histories

All Jefferies ratingsCHE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.